KRT84
gene geneOn this page
Also known as Hb-4
Summary
KRT84 (keratin 84, HGNC:6461) is a protein-coding gene on chromosome 12q13.13, encoding Keratin, type II cuticular Hb4 (Q9NSB2).
The protein encoded by this gene is a member of the keratin gene family. As a type II hair keratin, it is a basic protein which heterodimerizes with type I keratins to form hair and nails. The type II hair keratins are clustered in a region of chromosome 12q13 and are grouped into two distinct subfamilies based on structure similarity. One subfamily, consisting of KRTHB1, KRTHB3, and KRTHB6, is highly related. The other less-related subfamily includes KRTHB2, KRTHB4, and KRTHB5. All hair keratins are expressed in the hair follicle; this hair keratin is contained primarily in the filiform tongue papilla, among other hair keratins.
Source: NCBI Gene 3890 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 126 total
- MANE Select transcript:
NM_033045
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:6461 |
| Approved symbol | KRT84 |
| Name | keratin 84 |
| Location | 12q13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Hb-4 |
| Ensembl gene | ENSG00000161849 |
| Ensembl biotype | protein_coding |
| OMIM | 602766 |
| Entrez | 3890 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000257951
RefSeq mRNA: 1 — MANE Select: NM_033045
NM_033045
CCDS: CCDS8825
Canonical transcript exons
ENST00000257951 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000919885 | 52377812 | 52378380 |
| ENSE00000919886 | 52379876 | 52379907 |
| ENSE00000919887 | 52380363 | 52380583 |
| ENSE00000919888 | 52381080 | 52381205 |
| ENSE00000919890 | 52382437 | 52382532 |
| ENSE00000919892 | 52383590 | 52383798 |
| ENSE00000919893 | 52385040 | 52385652 |
| ENSE00001695106 | 52381361 | 52381525 |
| ENSE00001738900 | 52383005 | 52383065 |
Expression profiles
Bgee: expression breadth broad, 21 present calls, max score 42.46.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6548 / max 815.9880, expressed in 8 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 131027 | 0.6548 | 8 |
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| placenta | UBERON:0001987 | 42.46 | gold quality |
| tonsil | UBERON:0002372 | 40.24 | gold quality |
| skin of abdomen | UBERON:0001416 | 39.46 | gold quality |
| prefrontal cortex | UBERON:0000451 | 38.63 | silver quality |
| zone of skin | UBERON:0000014 | 37.67 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| skin of leg | UBERON:0001511 | 36.53 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.54 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.74 | gold quality |
| frontal cortex | UBERON:0001870 | 34.73 | silver quality |
| vagina | UBERON:0000996 | 33.31 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 32.62 | gold quality |
| muscle tissue | UBERON:0002385 | 32.06 | gold quality |
| cerebral cortex | UBERON:0000956 | 31.89 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 31.08 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 30.09 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| urinary bladder | UBERON:0001255 | 29.55 | gold quality |
| monocyte | CL:0000576 | 29.54 | gold quality |
| leukocyte | CL:0000738 | 29.36 | gold quality |
| liver | UBERON:0002107 | 29.25 | gold quality |
| right frontal lobe | UBERON:0002810 | 29.17 | gold quality |
| ectocervix | UBERON:0012249 | 28.60 | gold quality |
| spleen | UBERON:0002106 | 28.15 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.47 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting KRT84, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-6868-5P | 99.06 | 65.69 | 1284 |
| HSA-MIR-942-3P | 98.81 | 69.04 | 876 |
| HSA-MIR-1227-5P | 98.65 | 65.32 | 1549 |
| HSA-MIR-3135B | 98.61 | 65.33 | 1470 |
| HSA-MIR-4691-5P | 98.41 | 66.77 | 1343 |
| HSA-MIR-6792-3P | 98.41 | 66.86 | 1359 |
| HSA-MIR-22-5P | 97.67 | 68.92 | 1355 |
Literature-anchored findings (GeneRIF, showing 1)
- KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma. (PMID:32181476)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krt84 | ENSMUSG00000044294 |
| rattus_norvegicus | Krt84 | ENSRNOG00000008819 |
Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), KRT31 (ENSG00000094796), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT32 (ENSG00000108759), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), KRT33B (ENSG00000131738), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT38 (ENSG00000171360), KRT13 (ENSG00000171401)
Protein
Protein identifiers
Keratin, type II cuticular Hb4 — Q9NSB2 (reviewed: Q9NSB2)
Alternative names: Keratin-84, Type II hair keratin Hb4, Type-II keratin Kb24
All UniProt accessions (1): Q9NSB2
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Heterotetramer of two type I and two type II keratins.
Tissue specificity. Expressed in the hair follicles.
Miscellaneous. There are two types of hair/microfibrillar keratin, I (acidic) and II (neutral to basic).
Similarity. Belongs to the intermediate filament family.
RefSeq proteins (1): NP_149034* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003054 | Keratin_II | Family |
| IPR018039 | IF_conserved | Conserved_site |
| IPR032444 | Keratin_2_head | Domain |
| IPR039008 | IF_rod_dom | Domain |
Pfam: PF00038, PF16208
UniProt features (19 total): region of interest 7, sequence variant 5, sequence conflict 5, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NSB2-F1 | 68.52 | 0.45 |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 84 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT, GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_APPENDAGE_DEVELOPMENT, HFH8_01, FOXJ2_01, GOBP_MOLTING_CYCLE, GOBP_EPIDERMIS_DEVELOPMENT, AFP1_Q6, GOBP_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION, FOXJ2_02, GOBP_KERATINIZATION
GO Biological Process (5): hair follicle development (GO:0001942), keratinization (GO:0031424), nail development (GO:0035878), intermediate filament organization (GO:0045109), regulation of keratinocyte differentiation (GO:0045616)
GO Molecular Function (2): structural constituent of cytoskeleton (GO:0005200), structural constituent of skin epidermis (GO:0030280)
GO Cellular Component (5): cytosol (GO:0005829), keratin filament (GO:0045095), extracellular exosome (GO:0070062), intermediate filament (GO:0005882), intermediate filament cytoskeleton (GO:0045111)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
| Keratinization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| anatomical structure development | 2 |
| keratinocyte differentiation | 2 |
| structural molecule activity | 2 |
| cytoskeleton | 2 |
| hair cycle process | 1 |
| skin epidermis development | 1 |
| multicellular organismal process | 1 |
| limb development | 1 |
| intermediate filament cytoskeleton organization | 1 |
| supramolecular fiber organization | 1 |
| regulation of epidermal cell differentiation | 1 |
| cytoskeleton organization | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| extracellular vesicle | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
910 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRT84 | KRTAP3-1 | Q9BYR8 | 520 |
| KRT84 | OR6X1 | Q8NH79 | 506 |
| KRT84 | KRTAP13-1 | Q8IUC0 | 500 |
| KRT84 | HOXC13 | P31276 | 489 |
| KRT84 | DSG4 | Q86SJ6 | 453 |
| KRT84 | SELENBP1 | Q13228 | 426 |
| KRT84 | AKR1B10 | O60218 | 424 |
| KRT84 | MEPCE | Q7L2J0 | 424 |
| KRT84 | LY6D | Q14210 | 413 |
| KRT84 | SPRR4 | Q96PI1 | 398 |
| KRT84 | KRTAP19-7 | Q3SYF9 | 392 |
| KRT84 | PRSS53 | Q2L4Q9 | 388 |
| KRT84 | STARD9 | Q9P2P6 | 383 |
| KRT84 | PRR9 | Q5T870 | 375 |
| KRT84 | OR13J1 | Q8NGT2 | 375 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NEURL4 | APBB1 | psi-mi:“MI:0914”(association) | 0.530 |
| STARD8 | JPH1 | psi-mi:“MI:0914”(association) | 0.530 |
| CFTR | CNOT1 | psi-mi:“MI:0914”(association) | 0.480 |
| METTL3 | TUBAL3 | psi-mi:“MI:0914”(association) | 0.350 |
| CUL3 | PXDNL | psi-mi:“MI:0914”(association) | 0.350 |
| SLX1A | PSMD11 | psi-mi:“MI:0914”(association) | 0.350 |
| USP37 | ALB | psi-mi:“MI:0914”(association) | 0.350 |
| KATNIP | psi-mi:“MI:0914”(association) | 0.350 | |
| CFTR | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| SULF2 | IGHA1 | psi-mi:“MI:0914”(association) | 0.350 |
| ARMC9 | PRMT5 | psi-mi:“MI:0914”(association) | 0.350 |
| NRAS | IGKV2D-24 | psi-mi:“MI:0914”(association) | 0.350 |
| FHIP2A | MED19 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (51): KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-RNA), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS), KRT84 (Affinity Capture-MS)
ESM2 similar proteins: A0JND2, A3KN27, A5A6N0, A6BLY7, A6H712, A6QNX5, A7YWK3, E1AB55, P07744, P08729, P19013, P25691, Q0P5J4, Q0P5J6, Q0P5J7, Q0VBK2, Q148H5, Q148H6, Q148H7, Q148H8, Q14CN4, Q3SY84, Q5XKE5, Q64291, Q6IFW8, Q6IFZ9, Q6IG00, Q6IG01, Q6IG03, Q6IG04, Q6IME9, Q6IMF0, Q6IMF1, Q6KB66, Q6NXH9, Q6R649, Q7RTS7, Q7Z3Y7, Q7Z3Y9, Q7Z794
Diamond homologs: A0A8C0N8E3, A0JND2, A3KN27, A4FUZ0, A5A6M6, A5A6M8, A5A6N0, A6QNX5, A6QQJ3, A7YWK3, E1AB55, O43790, O93532, O95678, P02538, P04104, P04259, P04264, P04265, P04266, P05786, P05787, P07744, P08670, P08729, P08776, P11679, P12035, P13647, P15241, P15331, P16878, P18520, P19013, P21807, P25691, P35908, P41219, P48616, P48668
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
126 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 114 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1088 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:52379874:A:AC | donor_gain | 1.0000 |
| 12:52379875:C:CC | donor_gain | 1.0000 |
| 12:52380355:GTACT:G | donor_loss | 1.0000 |
| 12:52380357:ACT:A | donor_loss | 1.0000 |
| 12:52380359:TCA:T | donor_loss | 1.0000 |
| 12:52380360:CA:C | donor_loss | 1.0000 |
| 12:52380361:A:AC | donor_gain | 1.0000 |
| 12:52380361:A:T | donor_loss | 1.0000 |
| 12:52380361:AC:A | donor_gain | 1.0000 |
| 12:52380361:ACCGG:A | donor_gain | 1.0000 |
| 12:52380362:C:CG | donor_gain | 1.0000 |
| 12:52380362:CC:C | donor_gain | 1.0000 |
| 12:52380362:CCGG:C | donor_gain | 1.0000 |
| 12:52380362:CCGGC:C | donor_gain | 1.0000 |
| 12:52380580:CACG:C | acceptor_gain | 1.0000 |
| 12:52380582:CG:C | acceptor_gain | 1.0000 |
| 12:52380584:C:CC | acceptor_gain | 1.0000 |
| 12:52381075:CCCA:C | donor_loss | 1.0000 |
| 12:52381076:CCACC:C | donor_loss | 1.0000 |
| 12:52381077:CACCT:C | donor_loss | 1.0000 |
| 12:52381078:A:C | donor_loss | 1.0000 |
| 12:52381079:C:CT | donor_loss | 1.0000 |
| 12:52381105:G:GA | donor_gain | 1.0000 |
| 12:52381110:AAG:A | donor_gain | 1.0000 |
| 12:52381201:TCATA:T | acceptor_gain | 1.0000 |
| 12:52381202:CATA:C | acceptor_gain | 1.0000 |
| 12:52381202:CATAC:C | acceptor_gain | 1.0000 |
| 12:52381203:ATA:A | acceptor_gain | 1.0000 |
| 12:52381204:TA:T | acceptor_gain | 1.0000 |
| 12:52381206:C:CC | acceptor_gain | 1.0000 |
AlphaMissense
3920 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:52385058:A:C | F176L | 0.987 |
| 12:52385058:A:T | F176L | 0.987 |
| 12:52385060:A:G | F176L | 0.987 |
| 12:52383008:C:A | K271N | 0.977 |
| 12:52383008:C:G | K271N | 0.977 |
| 12:52385059:A:C | F176C | 0.964 |
| 12:52385059:A:G | F176S | 0.963 |
| 12:52383779:T:G | Q189P | 0.957 |
| 12:52385068:T:A | N173I | 0.954 |
| 12:52383020:A:C | F267L | 0.953 |
| 12:52383020:A:T | F267L | 0.953 |
| 12:52383022:A:G | F267L | 0.953 |
| 12:52380422:C:A | K455N | 0.950 |
| 12:52380422:C:G | K455N | 0.950 |
| 12:52383794:C:G | R184P | 0.950 |
| 12:52385067:G:C | N173K | 0.949 |
| 12:52385067:G:T | N173K | 0.949 |
| 12:52383782:T:G | Q188P | 0.939 |
| 12:52385049:G:C | F179L | 0.939 |
| 12:52385049:G:T | F179L | 0.939 |
| 12:52385051:A:G | F179L | 0.939 |
| 12:52385071:A:G | L172P | 0.938 |
| 12:52380384:A:G | L468P | 0.932 |
| 12:52383784:C:A | E187D | 0.926 |
| 12:52383784:C:G | E187D | 0.926 |
| 12:52381384:C:G | A352P | 0.925 |
| 12:52382458:A:C | F297L | 0.925 |
| 12:52382458:A:T | F297L | 0.925 |
| 12:52382460:A:G | F297L | 0.925 |
| 12:52385056:G:T | A177D | 0.925 |
dbSNP variants (sampled 300 via entrez): RS1000421639 (12:52379415 T>A), RS1001134522 (12:52379676 C>A), RS1001315457 (12:52380224 C>A), RS1001688382 (12:52380752 ATGGGGTAGGGCAT>A), RS1002026991 (12:52379588 G>C), RS1002566716 (12:52383876 A>G), RS1002637652 (12:52385274 AC>A,ACC), RS1002704386 (12:52377879 G>T), RS1002720110 (12:52388902 G>A,T), RS1002819919 (12:52380278 A>G), RS1002898668 (12:52387697 T>G), RS1002939648 (12:52388677 G>T), RS1003022482 (12:52382720 G>A,T), RS1003195648 (12:52383703 G>A), RS1003232261 (12:52386677 T>C)
Disease associations
OMIM: gene MIM:602766 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Caffeine | decreases expression | 1 |
| Phenolsulfonphthalein | affects cotreatment, increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.